Compare REPL & HTBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | REPL | HTBK |
|---|---|---|
| Founded | 2015 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 692.8M | 739.7M |
| IPO Year | 2018 | 1998 |
| Metric | REPL | HTBK |
|---|---|---|
| Price | $5.34 | $13.45 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 9 | 6 |
| Target Price | $5.67 | ★ $12.88 |
| AVG Volume (30 Days) | ★ 8.1M | 1.0M |
| Earning Date | 05-21-2026 | 04-24-2026 |
| Dividend Yield | N/A | ★ 3.87% |
| EPS Growth | 5.25 | ★ 18.18 |
| EPS | N/A | ★ 0.78 |
| Revenue | N/A | ★ $3,688,000.00 |
| Revenue This Year | N/A | $7.80 |
| Revenue Next Year | N/A | $5.51 |
| P/E Ratio | ★ N/A | $17.24 |
| Revenue Growth | N/A | ★ 3.57 |
| 52 Week Low | $1.50 | $8.95 |
| 52 Week High | $13.24 | $13.83 |
| Indicator | REPL | HTBK |
|---|---|---|
| Relative Strength Index (RSI) | 62.53 | 64.54 |
| Support Level | $4.39 | $11.85 |
| Resistance Level | $5.84 | $13.65 |
| Average True Range (ATR) | 0.53 | 0.31 |
| MACD | 0.43 | 0.07 |
| Stochastic Oscillator | 96.61 | 81.90 |
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
Heritage Commerce Corp operates as a bank holding company. The company, through its subsidiary, offers commercial banking services to small and medium-sized businesses and their owners, managers, and employees. It operates through two reportable segments, namely Banking and Factoring. Majority of its revenue is generated from the Banking segment, which provides various loan products, including commercial and industrial loans, commercial real estate loans, construction loans, etc. This segment also focuses on deposit generation on relationship accounts, encompassing non-interest bearing demand, interest bearing demand, money market accounts, certificates of deposit, and savings accounts.